FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2096155112> ?p ?o ?g. }

• W2096155112 endingPage "5470" @default.
• W2096155112 startingPage "5464" @default.
• W2096155112 abstract "ABSTRACT The Plasmodium vivax merozoite surface protein 1 (MSP-1) 42-kDa fragment (PvMSP-1 p42) is a promising vaccine candidate antigen against the blood stage of the malarial parasite. We have developed a process for the production of this vaccine target, keeping in mind its use in human volunteers. A novel strain, Origami(DE3), of Escherichia coli with mutations in the glutathione and thioredoxin reductase genes yielded 60% more soluble PvMSP-1 p42 than the conventional E. coli BL21(DE3) strain. Recombinant PvMSP-1 p42 was purified to ≥99% purity with a rapid two-step protocol designed for easy scaling up. The final product had a low endotoxin content and was stable in its lyophilized form. PvMSP-1 p42 was found to have the predicted primary and tertiary structures and consisted of a single conformer containing one free cysteine, as predicted. The product was recognized by conformational monoclonal antibodies against P. vivax MSP-1. Immunogenicity studies of PvMSP-1 p42 were carried out with two strains of mice and the adjuvants Montanide ISA51 and Montanide ISA720. Both formulations were found to induce high levels of immunoglobulin G1 (IgG1), IgG2b, and IgG2a antibodies along with low levels of IgG3. Lymphocytes from animals in all the PvMSP-1 p42-immunized groups showed proliferative responses upon stimulation with PvMSP-1 p42; the cytokines interleukin 2 (IL-2), gamma interferon, IL-4, and IL-10 were detected in the culture supernatants. These results indicate that PvMSP-1 p42 in combination with both of the adjuvants elicited cellular and humoral responses in mice." @default.
• W2096155112 created "2016-06-24" @default.
• W2096155112 creator A5008165819 @default.
• W2096155112 creator A5014264036 @default.
• W2096155112 creator A5022951811 @default.
• W2096155112 creator A5059907819 @default.
• W2096155112 creator A5080086000 @default.
• W2096155112 date "2001-09-01" @default.
• W2096155112 modified "2023-09-23" @default.
• W2096155112 title "Purification, Characterization, and Immunogenicity of a Disulfide Cross-Linked <i>Plasmodium vivax</i> Vaccine Candidate Antigen, Merozoite Surface Protein 1, Expressed in <i>Escherichia coli</i>" @default.
• W2096155112 cites W1818979383 @default.
• W2096155112 cites W1877738484 @default.
• W2096155112 cites W1904762770 @default.
• W2096155112 cites W1965543649 @default.
• W2096155112 cites W1973118547 @default.
• W2096155112 cites W1976237449 @default.
• W2096155112 cites W1977450646 @default.
• W2096155112 cites W1977789051 @default.
• W2096155112 cites W1989043630 @default.
• W2096155112 cites W2006370393 @default.
• W2096155112 cites W2019697277 @default.
• W2096155112 cites W2027534764 @default.
• W2096155112 cites W2059766541 @default.
• W2096155112 cites W2062502531 @default.
• W2096155112 cites W2080843329 @default.
• W2096155112 cites W2081488264 @default.
• W2096155112 cites W2083908099 @default.
• W2096155112 cites W2090978384 @default.
• W2096155112 cites W2098346284 @default.
• W2096155112 cites W2105666996 @default.
• W2096155112 cites W2114221281 @default.
• W2096155112 cites W2116038362 @default.
• W2096155112 cites W2127357344 @default.
• W2096155112 cites W2149516731 @default.
• W2096155112 cites W2156461736 @default.
• W2096155112 cites W2162358800 @default.
• W2096155112 cites W2169112284 @default.
• W2096155112 cites W2188554954 @default.
• W2096155112 cites W2414801566 @default.
• W2096155112 doi "https://doi.org/10.1128/iai.69.9.5464-5470.2001" @default.
• W2096155112 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/98658" @default.
• W2096155112 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11500418" @default.
• W2096155112 hasPublicationYear "2001" @default.
• W2096155112 type Work @default.
• W2096155112 sameAs 2096155112 @default.
• W2096155112 citedByCount "55" @default.
• W2096155112 countsByYear W20961551122012 @default.
• W2096155112 countsByYear W20961551122013 @default.
• W2096155112 countsByYear W20961551122014 @default.
• W2096155112 countsByYear W20961551122015 @default.
• W2096155112 countsByYear W20961551122016 @default.
• W2096155112 countsByYear W20961551122017 @default.
• W2096155112 countsByYear W20961551122019 @default.
• W2096155112 countsByYear W20961551122020 @default.
• W2096155112 countsByYear W20961551122021 @default.
• W2096155112 countsByYear W20961551122023 @default.
• W2096155112 crossrefType "journal-article" @default.
• W2096155112 hasAuthorship W2096155112A5008165819 @default.
• W2096155112 hasAuthorship W2096155112A5014264036 @default.
• W2096155112 hasAuthorship W2096155112A5022951811 @default.
• W2096155112 hasAuthorship W2096155112A5059907819 @default.
• W2096155112 hasAuthorship W2096155112A5080086000 @default.
• W2096155112 hasBestOaLocation W20961551122 @default.
• W2096155112 hasConcept C104317684 @default.
• W2096155112 hasConcept C147483822 @default.
• W2096155112 hasConcept C159047783 @default.
• W2096155112 hasConcept C159654299 @default.
• W2096155112 hasConcept C203014093 @default.
• W2096155112 hasConcept C2777023991 @default.
• W2096155112 hasConcept C2778048844 @default.
• W2096155112 hasConcept C2778371730 @default.
• W2096155112 hasConcept C2779997623 @default.
• W2096155112 hasConcept C2780868878 @default.
• W2096155112 hasConcept C2781034427 @default.
• W2096155112 hasConcept C40767141 @default.
• W2096155112 hasConcept C542903549 @default.
• W2096155112 hasConcept C547475151 @default.
• W2096155112 hasConcept C55493867 @default.
• W2096155112 hasConcept C86803240 @default.
• W2096155112 hasConcept C89423630 @default.
• W2096155112 hasConceptScore W2096155112C104317684 @default.
• W2096155112 hasConceptScore W2096155112C147483822 @default.
• W2096155112 hasConceptScore W2096155112C159047783 @default.
• W2096155112 hasConceptScore W2096155112C159654299 @default.
• W2096155112 hasConceptScore W2096155112C203014093 @default.
• W2096155112 hasConceptScore W2096155112C2777023991 @default.
• W2096155112 hasConceptScore W2096155112C2778048844 @default.
• W2096155112 hasConceptScore W2096155112C2778371730 @default.
• W2096155112 hasConceptScore W2096155112C2779997623 @default.
• W2096155112 hasConceptScore W2096155112C2780868878 @default.
• W2096155112 hasConceptScore W2096155112C2781034427 @default.
• W2096155112 hasConceptScore W2096155112C40767141 @default.
• W2096155112 hasConceptScore W2096155112C542903549 @default.
• W2096155112 hasConceptScore W2096155112C547475151 @default.
• W2096155112 hasConceptScore W2096155112C55493867 @default.
• W2096155112 hasConceptScore W2096155112C86803240 @default.
• W2096155112 hasConceptScore W2096155112C89423630 @default.
• W2096155112 hasIssue "9" @default.

• next